Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 6,599 | 10,056 | 12,192 | 21,543 | 101,383 |
| Gross Profit | 6,599 | 10,056 | 12,192 | 21,543 | 101,383 |
| Operating Expenses | 61,489 | 61,445 | 77,066 | 59,321 | 63,648 |
| Operating Income | -54,890 | -51,389 | -64,874 | -37,778 | 37,735 |
| Other Income | 15,614 | 13,385 | 16,726 | 6,367 | 8,852 |
| Pre-tax Income | -39,276 | -38,004 | -48,148 | -31,411 | 46,587 |
| Income Tax | -10,666 | -7,476 | -8,038 | -1,518 | 19,963 |
| Net Income Continuous | -28,610 | -30,528 | -40,110 | -29,893 | 26,624 |
| Net Income | $-28,610 | $-30,528 | $-40,110 | $-29,893 | $26,624 |
| EPS Basic Total Ops | -0.10 | -0.11 | -0.14 | -0.10 | 0.09 |
| EPS Basic Continuous Ops | -0.10 | -0.11 | -0.14 | -0.11 | 0.09 |
| EPS Diluted Total Ops | -0.10 | -0.11 | -0.14 | -0.10 | 0.08 |
| EPS Diluted Continuous Ops | -0.10 | -0.11 | -0.14 | -0.10 | 0.08 |
| EBITDA(a) | $-47,481 | $-44,133 | $-57,754 | $-22,418 | $44,463 |